Wedmont Private Capital

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1904274 WEST CHESTER, PA

Position in ALNY

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$425,355

+$21,032 QoQ

Shares Held

1,413

+15.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#19

of 51 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Jun 30, 2026

Wedmont Private Capital holds $14,119,633 across 15 Biotechnology names. ALNY ranks #8 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	40,281	$7,543,825
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,524	$1,750,476
3	REGN	Regeneron Pharmaceuticals, Inc.	1,310	$816,837
4	JAZZ	Jazz Pharmaceuticals plc	2,474	$596,159
5	ROIV	Roivant Sciences Ltd.	15,587	$551,623
6	IONS	Ionis Pharmaceuticals Inc	6,723	$533,066
7	EXEL	Exelixis, Inc.	8,342	$453,888
8	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,413	$425,355

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$425,355	1,413	+15.6%	Shares	Sole	2026-07-13
2026-03-31	$404,323	1,222	+9.8%	Shares	Sole	2026-04-09
2025-12-31	$442,584	1,113	+5.5%	Shares	Sole	2026-01-08
2025-09-30	$481,080	1,055	-40.1%	Shares	Sole	2025-10-08
2025-06-30	$574,244	1,761	+10.6%	Shares	Sole	2025-07-10
2025-03-31	$429,871	1,592	+7.2%	Shares	Sole	2025-04-14
2024-12-31	$349,435	1,485	+0.5%	Shares	Sole	2025-01-13
2024-09-30	$406,219	1,477	+19.7%	Shares	Sole	2024-10-08
2024-06-30	$299,862	1,234	+33.1%	Shares	Sole	2024-07-15
2022-12-31	$220,301	927	—	Shares	Sole	2023-01-09
No filing history on record for this holder in this stock.